Arcus Biosciences Inc. (RCUS)
NYSE: RCUS
· Real-Time Price · USD
10.37
0.46 (4.64%)
At close: Aug 15, 2025, 3:59 PM
10.64
2.60%
After-hours: Aug 15, 2025, 07:29 PM EDT
Arcus Biosciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 248M | 192M | 150M | 201M | 156M | 185M | 127M | 184M | 230M | 238M | 206M | 217.65M | 272.63M | 548.78M | 147.91M | 179.43M | 320.48M | 390.26M |
Short-Term Investments | 663M | 805M | 828M | 888M | 813M | 810M | 632M | 615M | 700M | 716M | 803M | 831.13M | 900.15M | 664.75M | 351.39M | 345.21M | 400.53M | 436.67M |
Long-Term Investments | 16M | 8M | 14M | 2M | 49M | 100M | 107M | 151M | 80M | 90M | 129M | 143.14M | 98.33M | 128.84M | 181.99M | 218.73M | 84.1M | 57.99M |
Other Long-Term Assets | 69M | 71M | 73M | 75M | 66M | 78M | 106M | 108M | 109M | 112M | 114M | 13.6M | 13.53M | 13.89M | 591.19M | 10.9M | 8.78M | 8.17M |
Receivables | 20M | 21M | 25M | 21M | 33M | 40M | 42M | 56M | 37M | 36M | 43M | 30.71M | 39.03M | 32.16M | 745M | 3.07M | 2.98M | 6.26M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -207M | -80M | -90M | -172M | n/a | n/a | n/a | -762.44M | n/a | n/a | n/a |
Other Current Assets | 15M | 13M | 13M | 17M | 20M | 29M | 30M | 27M | 19M | 25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 946M | 1.03B | 1.02B | 1.13B | 1.02B | 1.06B | 831M | 882M | 986M | 1.01B | 1.07B | 1.1B | 1.23B | 1.26B | 681.3M | 545.29M | 745.95M | 841.87M |
Property-Plant & Equipment | 44M | 46M | 47M | 48M | 49M | 51M | 51M | 50M | 45M | 37M | 35M | 135.97M | 137.44M | 136.47M | 137.42M | 64.37M | 59.94M | 27.09M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 129M | 125M | 134M | 125M | 164M | 229M | 264M | 309M | 234M | 239M | 278M | 292.71M | 249.3M | 279.2M | 910.6M | 294M | 152.82M | 93.25M |
Total Assets | 1.07B | 1.16B | 1.15B | 1.25B | 1.19B | 1.29B | 1.09B | 1.19B | 1.22B | 1.25B | 1.34B | 1.39B | 1.48B | 1.54B | 1.59B | 839.29M | 898.77M | 935.12M |
Account Payables | 29M | 22M | 18M | 13M | 15M | 16M | 17M | 17M | 12M | 28M | 20M | 10.55M | 21.98M | 18.09M | 10.26M | 13.22M | 16.96M | 24.54M |
Deferred Revenue | 71M | 72M | 85M | 105M | 113M | 124M | 91M | 103M | 103M | 97M | 97M | 103.29M | 90.12M | 89.31M | 102M | 74.34M | 74.57M | 74.57M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 16M | 17M | 14M | 86M | 40M | 38M | 39M | 46M | 48M | 41M | 48M | 45.32M | 38.96M | 39.37M | 5.08M | 41.8M | 30.24M | 25.81M |
Total Current Liabilities | 210M | 192M | 226M | 215M | 199M | 204M | 184M | 200M | 180M | 179M | 193M | 177.18M | 164.02M | 161.25M | 166.08M | 142.87M | 130.37M | 132.06M |
Long-Term Debt | 97M | 48M | 48M | 47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 159M | 166M | 157M | 425M | 138M | 140M | 142M | 145M | 144M | 145M | 140M | 16.17M | 14.68M | 13.87M | 5.26M | 10.2M | 10.2M | 10.2M |
Total Long-Term Liabilities | 316M | 433M | 439M | 472M | 352M | 382M | 449M | 471M | 474M | 475M | 495M | 517.95M | 565.36M | 585.59M | 584.36M | 153.82M | 163.85M | 138.27M |
Total Liabilities | 526M | 625M | 665M | 687M | 551M | 586M | 633M | 671M | 654M | 654M | 688M | 695.12M | 729.39M | 746.85M | 750.45M | 296.68M | 294.22M | 270.33M |
Total Debt | 109M | 60M | 60M | 58M | 11M | 11M | 11M | 9M | 116M | 120M | 120M | 119.19M | 121.34M | 114.81M | 116.89M | 48.94M | 49.74M | 14.71M |
Common Stock | 1.79B | 1.77B | 1.62B | 1.6B | 1.58B | 1.56B | 1.31B | 1.29B | 1.27B | 1.23B | 1.21B | 7K | 7K | 7K | 7K | 7K | 7K | 7K |
Retained Earnings | -1.24B | -1.24B | -1.13B | -1.04B | -946M | -853M | -849M | -768M | -697M | -622M | -542M | -474.9M | -409.98M | -343.35M | -275.35M | -554.72M | -476.75M | -400.78M |
Comprehensive Income | n/a | n/a | n/a | 1M | -1M | -1M | n/a | -3M | -4M | -4M | -7M | -9.8M | -7.24M | -4.66M | -1.26M | -92K | -46K | -2K |
Shareholders Equity | 549M | 531M | 485M | 565M | 635M | 707M | 462M | 520M | 566M | 600M | 657M | 698.7M | 747.39M | 796.58M | 841.45M | 542.61M | 604.55M | 664.79M |
Total Investments | 679M | 813M | 842M | 890M | 862M | 910M | 739M | 766M | 780M | 806M | 932M | 974.27M | 998.48M | 793.59M | 533.38M | 563.94M | 484.63M | 494.65M |